Phenotypic characterization of CD8+ T cells in various lymphoid compartments of SIVmac-infected rhesus monkeys
Cell subset . | % CD8+ T cells staining3-150 . | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
575 . | 3KI . | IPI . | 297 . | |||||||||||||||||
LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | |
CD11a+ | 84 | 93 | 81 | 88 | NT3-151 | 94 | 99 | 94 | 97 | NT | 99 | 98 | 98 | 98 | 95 | 36 | 61 | NT | 25 | 97 |
CD28+ | 51 | 11 | 21 | 23 | NT | 63 | 36 | 29 | 68 | NT | 88 | 75 | 64 | 88 | 85 | 81 | 49 | 66 | 53 | 90 |
CD45RA+ | 27 | 14 | 11 | NT | NT | 17 | 16 | 13 | 17 | NT | 26 | 20 | 22 | 25 | 1.5 | 55 | 51 | 17 | 84 | 3.3 |
CD49d+ | 90 | 91 | 93 | NT | NT | 90 | 97 | 93 | 90 | NT | 89 | 91 | 98 | 90 | 97 | 95 | 80 | NT | NT | 98 |
CD62L+ | 24 | 3.3 | 2.7 | NT | NT | 13 | 4.8 | 5.3 | 12 | NT | 28 | 19 | 11 | 19 | 65 | 57 | 14 | 32 | 37 | 62 |
CD95+ | 90 | 98 | 98 | NT | NT | 95 | 97 | 98 | 95 | NT | 97 | 99 | 98 | 97 | 87 | 39 | 64 | NT | 28 | 3.1 |
MHC class II DR+ | 60 | 85 | 58 | NT | NT | 78 | 94 | 90 | 83 | NT | 76 | 87 | 78 | 68 | 30 | 25 | 61 | 54 | 23 | 34 |
Cell subset . | % CD8+ T cells staining3-150 . | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
575 . | 3KI . | IPI . | 297 . | |||||||||||||||||
LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | |
CD11a+ | 84 | 93 | 81 | 88 | NT3-151 | 94 | 99 | 94 | 97 | NT | 99 | 98 | 98 | 98 | 95 | 36 | 61 | NT | 25 | 97 |
CD28+ | 51 | 11 | 21 | 23 | NT | 63 | 36 | 29 | 68 | NT | 88 | 75 | 64 | 88 | 85 | 81 | 49 | 66 | 53 | 90 |
CD45RA+ | 27 | 14 | 11 | NT | NT | 17 | 16 | 13 | 17 | NT | 26 | 20 | 22 | 25 | 1.5 | 55 | 51 | 17 | 84 | 3.3 |
CD49d+ | 90 | 91 | 93 | NT | NT | 90 | 97 | 93 | 90 | NT | 89 | 91 | 98 | 90 | 97 | 95 | 80 | NT | NT | 98 |
CD62L+ | 24 | 3.3 | 2.7 | NT | NT | 13 | 4.8 | 5.3 | 12 | NT | 28 | 19 | 11 | 19 | 65 | 57 | 14 | 32 | 37 | 62 |
CD95+ | 90 | 98 | 98 | NT | NT | 95 | 97 | 98 | 95 | NT | 97 | 99 | 98 | 97 | 87 | 39 | 64 | NT | 28 | 3.1 |
MHC class II DR+ | 60 | 85 | 58 | NT | NT | 78 | 94 | 90 | 83 | NT | 76 | 87 | 78 | 68 | 30 | 25 | 61 | 54 | 23 | 34 |
Values represent the percentages of lymph nodes (LNs) [median of % in lymph nodes that were sampled simultaneously (mandibular, axillary, inguinal, mesenteric, iliac)], spleen (Sp), bone marrow (BM), tonsil (Ton), and thymus (Thy) cells staining for expression of CD11a, CD28, CD45RA, CD49d, CD62L, CD95, and MHC class II-DR on CD8+ T cells. CD8+ T cells are defined by gating on CD8αβ+ CD3+ cells.
NT, not tested.